IQVIA's Drug Discovery & Development Services use AI and machine learning to transform R&D and expedite the drug discovery and development process.
- Learn how AI is shifting the drug discovery paradigm by extracting hidden patterns and evidence from vast biomedical data.
- Discover how coupling AI with big data will dramatically improve drug repurposing effectiveness and efficiency.
- Explore how AI/ML can be used to mine old drugs for new applications to bring treatments to patients faster.
Related solutions
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Learn how unparalleled data, domain expertise, and technologies enable AI-powered solutions that are purpose-built for healthcare.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
See where IQVIA is questioning the status quo and investing in new technologies and methodologies to change how things are done.
